Nader S, Schultz P N, Fuller L M, Samaan N A
Arch Intern Med. 1984 Aug;144(8):1577-8.
Substantial evidence links the development of primary hyperparathyroidism with a medical history of neck radiation therapy for benign disease. This report concerns 220 patients with Hodgkin's disease seen at The University of Texas M. D. Anderson Hospital, Houston, treated with neck irradiation. Serum calcium levels had been analyzed two to 22 years after radiotherapy. Hyperparathyroidism was confirmed at surgery in one patient with hypercalcemia 15 years after radiotherapy. However, the maximum follow-up was 22 years and in a reported series the mean interval between irradiation and the development of hyperparathyroidism has ranged from 29 to 47 years. We conclude that patients who have received neck radiation therapy for malignant disease are not at an increased risk for the development of hyperparathyroidism in the first two decades following treatment but should continue to be screened for this development in subsequent decades.
大量证据表明,原发性甲状旁腺功能亢进症的发生与因良性疾病接受颈部放射治疗的病史有关。本报告涉及在休斯顿的德克萨斯大学MD安德森医院接受颈部照射治疗的220例霍奇金病患者。放疗后2至22年对血清钙水平进行了分析。一名患者在放疗15年后因高钙血症在手术中被确诊为甲状旁腺功能亢进症。然而,最长随访时间为22年,在一个报道的系列中,照射与甲状旁腺功能亢进症发生之间的平均间隔时间为29至47年。我们得出结论,因恶性疾病接受颈部放射治疗的患者在治疗后的前二十年发生甲状旁腺功能亢进症的风险并未增加,但在随后的几十年中仍应继续筛查是否发生这种情况。